Sands Capital Management - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 406 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
Sands Capital Management ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$120,568,860
+43149.4%
874,765
-59.3%
0.40%
-62.3%
Q4 2022$278,776
-99.9%
2,151,378
-13.3%
1.05%
+2.2%
Q3 2022$274,402,000
-1.4%
2,482,375
-33.1%
1.03%
+7.0%
Q2 2022$278,184,000
-25.5%
3,711,101
-22.4%
0.96%
+12.1%
Q1 2022$373,644,000
-22.7%
4,782,951
-10.8%
0.86%
-4.1%
Q4 2021$483,085,000
-6.2%
5,364,627
-3.6%
0.90%
+4.4%
Q3 2021$514,753,000
+18.1%
5,566,103
-0.7%
0.86%
+16.1%
Q2 2021$435,900,000
+93.1%
5,607,148
+85.2%
0.74%
+69.5%
Q1 2021$225,684,000
-32.3%
3,028,090
+54.9%
0.44%
+37.5%
Q4 2020$333,184,000
+27.2%
1,954,272
+4.8%
0.32%
-44.1%
Q3 2020$261,967,000
-62.3%
1,865,463
-57.0%
0.57%
-66.3%
Q2 2020$695,756,000
+61.5%
4,339,256
-1.4%
1.68%
+17.3%
Q1 2020$430,695,000
-26.8%
4,402,931
-3.4%
1.44%
-15.9%
Q4 2019$588,100,000
+97.6%
4,557,499
+15.3%
1.71%
+78.5%
Q3 2019$297,671,000
-44.4%
3,952,090
+12.1%
0.96%
-39.9%
Q2 2019$535,711,000
+24.3%
3,525,576
-2.5%
1.59%
+19.9%
Q1 2019$431,121,000
+27.7%
3,617,094
+16.9%
1.33%
+10.3%
Q4 2018$337,732,000
+10.0%
3,094,767
+62.7%
1.20%
+38.8%
Q3 2018$307,122,0001,901,5640.87%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 290,000$44,066,0009.14%
Avoro Capital Advisors LLC 1,400,000$212,730,0007.35%
NEXTHERA CAPITAL LP 50,317$7,646,0006.37%
Eventide Asset Management 1,123,000$170,640,0005.19%
RTW INVESTMENTS, LP 604,236$91,814,0004.90%
Casdin Capital, LLC 335,000$50,903,250,0004.76%
Copernicus Capital Management, LLC 30,000$4,559,0004.06%
CADIAN CAPITAL MANAGEMENT, LP 548,500$83,345,0003.76%
Camber Capital Management LP 500,000$75,975,0003.54%
Dynamic Capital Management Ltd 4,677$711,0003.54%
View complete list of SAREPTA THERAPEUTICS INC shareholders